Improvement of Airflow Limitation by Fluticasone Propionate/Salmeterol in Chronic Obstructive Pulmonary Disease: What is the Specific Marker?

Backgrounds: Inhaled corticosteroids (ICS)/inhaled long-acting beta(2)-agonists (LABA) combination drugs are widely used for the long-term management of chronic obstructive pulmonary disease (COPD). However, COPD is a heterogeneous condition and treatment with ICS is associated with a higher risk of...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Akamatsu, Keiichiro, Matsunaga, Kazuto, Sugiura, Hisatoshi, Koarai, Akira, Hirano, Tsunahiko, Minakata, Yoshiaki, Ichinose, Masakazu
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Frontiers Research Foundation 2011
Gaiak:
Pharmacology
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3140651/
https://ncbi.nlm.nih.gov/pubmed/21811461
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2011.00036
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak